Latest Regulatory News

Page 669 of 744
Artemis Resources has clarified the permitting status of its Radio Hill processing plant and outlined the regulatory and operational steps required to resume processing activities, while granting Greentech Metals an exclusive option to assess copper ore feasibility.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Recce Pharmaceuticals reports strong Phase II results for its RECCE® 327 topical gel, achieving a 93% efficacy rate in treating serious skin infections and setting the stage for accelerated Phase 3 trials.
Victor Sage
Victor Sage
17 Feb 2025
Smart Parking Limited has reported robust H1 FY25 results, underpinned by a strategic acquisition of Peak Parking LP and a fully underwritten $45 million equity raise to fund its US expansion.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Smart Parking Limited has reported a robust half-year performance with a 20% increase in revenue and a 70% rise in net profit, driven by international expansion and operational growth across multiple markets.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Triangle Energy reports a missed payment from Pilot Energy related to the Cliff Head project sale, while Pilot continues funding operational costs amid capital raise talks.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Acorn Capital Investment Fund Limited has been suspended from ASX trading due to a delayed periodic report, raising questions about its compliance and investor transparency.
Claire Turing
Claire Turing
17 Feb 2025
Carbonxt Group Limited has initiated a $2 million Share Purchase Plan following successful capital raises, aiming to bolster its Kentucky activated carbon facility as it nears commercial production.
Victor Sage
Victor Sage
17 Feb 2025
Prodigy Gold NL has unveiled its comprehensive exploration plans for 2025, targeting resource expansion at Hyperion and Tregony deposits while advancing development options at Old Pirate. The company aims to leverage drilling results and metallurgical studies to accelerate project development in the Northern Territory.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.
Ada Torres
Ada Torres
17 Feb 2025
FBR Limited’s exclusive joint venture option with CRH Ventures for its Wall as a Service® offering in the US has expired without exercise, freeing the company to pursue independent financing and partnerships across key American markets.
Sophie Babbage
Sophie Babbage
17 Feb 2025
Larvotto Resources has modified its Hillgrove Antimony-Gold Project to adopt dry stacking for tailings, a move that promises environmental benefits and faster regulatory approval without impacting project economics.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Aurizon Holdings Limited has announced a six-month ordinary dividend of AUD 0.092 per share, payable on March 26, 2025, with 60% franking reflecting ongoing profitability.
Victor Sage
Victor Sage
17 Feb 2025